| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020128741 |
| P356 | DOI | 10.1208/S12249-014-0127-6 |
| P932 | PMC publication ID | 4113616 |
| P698 | PubMed publication ID | 24806822 |
| P5875 | ResearchGate publication ID | 264543242 |
| P50 | author | Hui Xin Ong | Q39187180 |
| Daniela Traini | Q39187198 | ||
| P2093 | author name string | Paul M Young | |
| Paolo Colombo | |||
| Alaa S Tulbah | |||
| P2860 | cites work | Statins as potential therapeutic drug for asthma? | Q26864029 |
| Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma | Q28362343 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Statins for sepsis: a critical and updated review | Q33439185 | ||
| Associations between statins and COPD: a systematic review. | Q33481269 | ||
| Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors | Q34207135 | ||
| Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation | Q34305806 | ||
| Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies. | Q34615434 | ||
| Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury. | Q34840907 | ||
| Statins as anti-inflammatory agents | Q34942903 | ||
| The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers | Q35006621 | ||
| Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis | Q35999292 | ||
| Statins and sepsis: multiple modifications at multiple levels. | Q36797719 | ||
| Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers | Q37225099 | ||
| Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management | Q37880077 | ||
| Solubility enhancement of simvastatin: a review. | Q38033184 | ||
| Statins in the treatment of asthma | Q38139272 | ||
| Statins do more than just lower cholesterol | Q41169571 | ||
| Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer | Q42564072 | ||
| Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase | Q42870324 | ||
| Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering | Q43516483 | ||
| Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction | Q44138516 | ||
| Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease | Q44358876 | ||
| Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers | Q44489473 | ||
| Statin therapy does not improve lung function in asthma: a meta-analysis of randomized controlled trials | Q44651861 | ||
| A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma | Q44772777 | ||
| A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions | Q44965513 | ||
| Spray pattern analysis for metered dose inhalers I: Orifice size, particle size, and droplet motion correlations | Q47319458 | ||
| Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 | ||
| A novel apparatus for the determination of solubility in pressurized metered dose inhalers. | Q51107638 | ||
| Statin use is associated with reduced mortality in COPD. | Q51779682 | ||
| Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Q67685401 | ||
| Statins as a newly recognized type of immunomodulator | Q73252634 | ||
| Modulation of aerosol clouds produced by pressurised inhalation aerosols | Q78199064 | ||
| Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan | Q80528540 | ||
| Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma | Q83426446 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | simvastatin | Q670131 |
| P304 | page(s) | 956-962 | |
| P577 | publication date | 2014-05-08 | |
| P1433 | published in | AAPS PharmSciTech | Q15750612 |
| P1476 | title | Novel simvastatin inhalation formulation and characterisation | |
| P478 | volume | 15 |
| Q35735440 | Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells. |
| Q90169812 | CAV1 - GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer |
| Q52716104 | Farnesyltransferase Inhibition Exacerbates Eosinophilic Inflammation and Airway Hyperreactivity in Mice with Experimental Asthma: The Complex Roles of Ras GTPase and Farnesylpyrophosphate in Type 2 Allergic Inflammation. |
| Q47755402 | Inhaled simvastatin nanoparticles for inflammatory lung disease |
| Q52633072 | Innovations in asthma therapy: is there a role for inhaled statins? |
| Q42530785 | Intratracheal instillation of pravastatin for the treatment of murine allergic asthma: a lung-targeted approach to deliver statins |
| Q36044812 | Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils |
| Q93169465 | Simvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages |
Search more.